People: Zimmer Holdings Inc (ZMH)

ZMH on New York Consolidated

113.77USD
22 May 2015
Change (% chg)

$-0.69 (-0.60%)
Prev Close
$114.46
Open
$114.08
Day's High
$114.47
Day's Low
$113.23
Volume
1,013,332
Avg. Vol
1,113,830
52-wk High
$121.84
52-wk Low
$94.73

Search Stocks

Summary

Name Age Since Current Position

Larry Glasscock

67 2013 Independent Non-Executive Chairman of the Board

David Dvorak

51 2007 President, Chief Executive Officer, Director

James Crines

55 2007 Executive Vice President - Finance, Chief Financial Officer

Joseph Cucolo

55 2012 President, Americas

Katarzyna Mazur-Hofsaess

51 2013 President, Europe, Middle East and Africa

Stephen Ooi

61 2005 President, Asia Pacific

Chad Phipps

43 2007 Senior Vice President, General Counsel, Secretary

Derek Davis

46 2007 Vice President - Finance, Corporate Controller, Chief Accounting Officer

Michael Farrell

42 2014 Director

Christopher Begley

62 2012 Independent Director

Betsy Bernard

60 2009 Independent Director

Paul Bisaro

54 2013 Independent Director

Gail Boudreaux

54 2012 Independent Director

Robert Hagemann

58 2008 Independent Director

Arthur Higgins

59 2007 Independent Director

Cecil Pickett

69 2008 Independent Director

Robert Marshall

Vice President - Investor Relations, Treasurer

Biographies

Name Description

Larry Glasscock

Mr. Larry C. Glasscock is an Independent Non-Executive Chairman of the Board of Zimmer Holdings, Inc. He served as the Chairman of Anthem, Inc. (formerly known as WellPoint, Inc.) from May 2003 until his retirement in March 2010. Mr. Glasscock also served as President and Chief Executive Officer of Anthem, Inc. from July 2001 until his retirement from day-to-day operations in June 2007. Mr. Glasscock earned a B.B.A. from Cleveland State University. He also completed the Commercial Bank Management Program at Columbia University.

David Dvorak

Mr. David C. Dvorak is the President, Chief Executive Officer, Director of Zimmer Holdings, Inc. Prior to that, Mr. Dvorak served as Group President, Global Businesses and Chief Legal Officer from December 2005. From October 2003 to December 2005, he served as Executive Vice President, Corporate Services, Chief Counsel and Secretary, as well as Chief Compliance Officer. Mr. Dvorak joined Zimmer in 2001. He earned a B.S. in business administration (finance) from Miami University (Ohio) and a J.D., magna cum laude, from Case Western Reserve University School of Law.

James Crines

Mr. James T. Crines is the Executive Vice President - Finance, Chief Financial Officer of Zimmer Holdings, Inc. From December 2005 to April 2007, he served as Senior Vice President, Finance, Operations and Corporate Controller and Chief Accounting Officer. Prior to that, he had served as Senior Vice President, Finance/Controller and Information Technology since October 2003.

Joseph Cucolo

Mr. Joseph A. Cucolo is the President, Americas of Zimmer Holdings, Inc. He is responsible for sales and management of the direct and indirect sales channels in the Americas region, including the United States, Canada and Latin America. From 1997 until he joined Zimmer as President, Americas, Mr. Cucolo was sole owner and President of Zimmer New England, Inc., an independent third-party distributor of Zimmer products in the northeast region of the United States. Prior to that, Mr. Cucolo was employed by Zimmer as a sales representative and territory manager in the New York area from 1987 to 1997.

Katarzyna Mazur-Hofsaess

Dr. Katarzyna Mazur-Hofsaess, M.D., Ph.D. is the President, Europe, Middle East and Africa of Zimmer Holdings, Inc. She is responsible for the sales, marketing and distribution of products in the European, Middle Eastern and African (EMEA) regions. Dr. Mazur-Hofsaess joined Zimmer in February 2010 as Senior Vice President, EMEA Sales and Marketing and was appointed President, EMEA Reconstructive in February 2012. She has approximately 20 years’ experience within the pharmaceutical, diagnostics and medical device sectors. Prior to joining Zimmer, Dr. Mazur-Hofsaess served in various management positions with Abbott Laboratories since 2001, including service as Vice President, Diagnostics – Europe.

Stephen Ooi

Mr. Stephen H. L. Ooi is the President, Asia Pacific of Zimmer Holdings, Inc. He is responsible for the financial performance of the business in the Asia Pacific region, including sales, marketing and distribution of products. Prior to being appointed President, Asia Pacific, Mr. Ooi had served as President, Australasia since September 2003.

Chad Phipps

Mr. Chad F. Phipps is the Senior Vice President, General Counsel, Secretary of Zimmer Holdings, Inc. He has global responsibility for our legal affairs and he serves as Secretary to the Board of Directors. Mr. Phipps also oversees our Corporate Compliance, Government Affairs, Corporate Marketing and Communications and Public Relations activities. From December 2005 to May 2007, he served as Associate General Counsel and Corporate Secretary. Prior to that, he had served as Associate Counsel and Assistant Secretary since September 2003.

Derek Davis

Mr. Derek M. Davis is the Vice President - Finance, Corporate Controller, Chief Accounting Officer of Zimmer Holdings, Inc. He has responsibility for internal and external reporting, planning and analysis, and corporate and business unit accounting. From March 2006 to May 2007, he served as Director, Financial Planning and Accounting. Prior to that, he had served as Director, Finance, Operations and Logistics since December 2003.

Michael Farrell

Mr. Michael J. Farrell is the Director of Zimmer Holdings, Inc. Mr. Farrell has served as the Chief Executive Officer of ResMed Inc. since March 2013. Prior to that appointment, Mr. Farrell served as President – Americas for ResMed from 2011 to 2013. He was previously Senior Vice President of the global business unit for sleep apnea therapeutic and diagnostic devices from 2007 to 2011, and before that he held various senior roles in marketing and business development. Before joining ResMed in September 2000, Mr. Farrell worked in management consulting, biotechnology, chemicals and metals manufacturing at Arthur D. Little, Genzyme Corporation, The Dow Chemical Company and BHP Billiton. Mr. Farrell holds a bachelor of engineering, with first-class honors, from the University of New South Wales, a master of science in chemical engineering from the Massachusetts Institute of Technology and an MBA from the MIT Sloan School of Management.

Christopher Begley

Mr. Christopher B. Begley is an Independent Director of Zimmer Holdings, Inc. He served as the Executive Chairman of the Board of Hospira, Inc. from May 2007 until his retirement in January 2012. Mr. Begley also served as Chief Executive Officer from April 30, 2004, when Hospira was spun off from Abbott Laboratories, to March 2011. Prior to that, Mr. Begley served in various positions with Abbott between 1986 and 2004, most recently as Senior Vice President of Abbott’s Hospital Products division. He earned a bachelor’s degree from Western Illinois University and an MBA from Northern Illinois University.

Betsy Bernard

Ms. Betsy J. Bernard is an Independent Director of Zimmer Holdings, Inc. Ms. bernard is the President of AT&T Corp. from October 2002 until her retirement in December 2003. From April 2001 to October 2002, Ms. Bernard was Chief Executive Officer of AT&T Consumer. Prior to joining AT&T, Ms. Bernard held senior executive positions with Qwest Communications International Inc., US WEST, Inc., AVIRNEX Communications Group and Pacific Bell. Ms. Bernard received a B.A. degree from St. Lawrence University, an MBA from Fairleigh Dickenson University and an M.S. in management from Stanford University’s Sloan Fellowship Program.

Paul Bisaro

Mr. Paul M. Bisaro is an Independent Director of Zimmer Holdings, Inc. Mr. Bisaro has been Executive Chairman of Actavis plc since July 2014. Mr. Bisaro served as Chairman, President and Chief Executive Officer of Actavis until June 2014. He was appointed President and Chief Executive Officer and a member of the board of directors of Actavis in 2007 and he was appointed Chairman of the Board in October 2013. Prior to joining Actavis (formerly Watson Pharmaceuticals), Mr. Bisaro served as President, Chief Operating Officer and a member of the board of directors of Barr Pharmaceuticals, Inc. from 1999 to 2007. Between 1992 and 1999, Mr. Bisaro served as General Counsel of Barr. Prior to joining Barr, Mr. Bisaro was associated with the law firm Winston & Strawn and a predecessor firm, Bishop, Cook, Purcell and Reynolds, from 1989 to 1992. Mr. Bisaro holds an undergraduate degree in general studies from the University of Michigan and a J.D. from Catholic University of America in Washington, D.C.

Gail Boudreaux

Ms. Gail Koziara Boudreaux is an Independent Director of Zimmer Holdings, Inc. Ms. Boudreaux was the Chief Executive Officer of UnitedHealthcare from January 2011 to November 2014 and Executive Vice President of UnitedHealth Group from May 2008 to February 2015. From 2005 to 2008, Ms. Boudreaux served as Executive Vice President, External Operations for Health Care Services Corporation (“HCSC”), and prior to that served as President of Blue Cross and Blue Shield of Illinois, a division of HCSC. Before joining HCSC, Ms. Boudreaux held various positions at Aetna, including Senior Vice President, Aetna Group Insurance. Ms. Boudreaux earned a bachelor’s degree in psychology from Dartmouth College and an MBA from Columbia Business School.

Robert Hagemann

Mr. Robert A. Hagemann is an Independent Director of Zimmer Holdings, Inc. He served as the Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated until his retirement in July 2013. Mr. Hagemann joined Corning Life Sciences, Inc., a subsidiary of Quest Diagnostics’ former parent company, Corning Incorporated, in 1992, and held roles of increasing responsibility before being appointed Chief Financial Officer of Quest Diagnostics in 1998. Prior to joining Corning, Mr. Hagemann held senior financial positions at Prime Hospitality, Inc. and Crompton & Knowles, Inc. He was also previously employed by Arthur Young & Co., a predecessor company to Ernst & Young. Mr. Hagemann holds a B.S. in accounting from Rider University and an MBA from Seton Hall University.

Arthur Higgins

Mr. Arthur J. Higgins is an Independent Director of Zimmer Holdings, Inc. He is the Consultant, Blackstone Healthcare Partners of The Blackstone Group, since June 2010. Prior to that, Mr. Higgins served as Chairman of the Board of Management of Bayer HealthCare AG from January 2006 to May 2010 and Chairman of the Bayer HealthCare Executive Committee from July 2004 to May 2010. Prior to joining Bayer HealthCare in 2004, Mr. Higgins served as Chairman, President and Chief Executive Officer of Enzon Pharmaceuticals, Inc. from 2001 to 2004. Prior to that, Mr. Higgins spent 14 years with Abbott Laboratories, most recently as President of the Pharmaceutical Products Division from 1998 to 2001. He graduated from Strathclyde University, Scotland and holds a B.S. in biochemistry.

Cecil Pickett

Dr. Cecil B. Pickett, Ph.D., is an Independent Director of Zimmer Holdings, Inc. He is the President, Research and Development and a member of the board of directors of Biogen Idec Inc. from September 2006 until his retirement in October 2009. Prior to joining Biogen Idec, Dr. Pickett held several senior R&D positions, including Corporate Senior Vice President of Schering-Plough Corp. and President of Schering-Plough Research Institute. Prior to joining Schering-Plough, he held several senior R&D positions at Merck & Co. Dr. Pickett received a B.S. in biology from California State University at Hayward and a Ph.D. in cell biology from University of California at Los Angeles.

Robert Marshall

Options Compensation

Search Stocks